Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Hospital Medicine
Addiction
Questions discussed in this category
What are your preferred non-benzodiazepine therapies for the hyperactive/agitated phase of methamphetamine withdrawal, both in the hospital and in the office?
Assume QTc is not prolonged, electrolytes are reasonably normal, and the patient is not already on heavy psychotropic polypharmacy.
2 Answers available
When do you consider using phenobarbital over symptom-driven alcohol withdrawal protocols for patients at low-to-moderate risk of withdrawal complications?
1 Answer available
What adjunctive therapies to you recommend for symptom control in acute opioid withdrawal beyond full/partial opioid agonists?
1 Answer available
Do you routinely prescribe naloxone at discharge for patients with a known history of opioid use disorder?
2 Answers available
Do you have any concerns about administering a Vivitrol injection when a patient has severe coagulopathy and/or thrombocytopenia related to cirrhosis?
1 Answer available
What precautions should be taken when discharging a patient from the medical setting on new medication assisted therapy for alcohol use disorder?
This is based on the recent publication by Bernstein et al., PMID 38551564 which investigated the increased rate of initiation of MAUD in the hospital...
5 Answers available
How do you decide whether to start MAT for opioid use disorder during hospitalization?
1 Answer available
What strategies do you find most effective at managing opioid withdrawal in hospitalized patients who are not interested in MAT?
2 Answers available
What recommendations do you have regarding the use of dronabinol to prevent cannabis withdrawal in an inpatient medical or psychiatric setting?
2 Answers available
23785
23153
25317
23154
25087
20828
23152
23500
20136
Papers discussed in this category
Scientific reports, 2023 Nov 28
Semaglutide and Tirzepatide reduce alcohol consumption in individuals with obesity.
JCI insight, 2023 Jun 22
The glucagon-like peptide-1 (GLP-1) analogue semaglutide reduces alcohol drinking and modulates central GABA neurotransmission.
Related Topics in Hospital Medicine
Lung Cancer
Breast Cancer
Head and Neck Cancers
Hematologic Malignancies
Radiation Oncology
Gynecologic Oncology
Palliation
Neuro-Oncology
Gastrointestinal Cancers
Genitourinary Cancers